-
A single dose of 1.5-mg levonorgestrel and a single low dose of 10-mg mifepristone are effective methods for emergency contraception.
-
Ventilation/perfusion scanning appears to be safe and effective, at least in ruling out significant clinical pulmonary embolism in pregnant patients. However, prospective studies over longer time periods should be undertaken to validate these conclusions.
-
The FDA has mandated a Black Box warning for all estrogen and estrogen/progestin products for use by postmenopausal women. The new warnings are based on analysis of data from the Womens Health Initiative (WHI) study that was published July 2002.
-
Vessey, Painter, and Yeates from the University of Oxford used the prospective cohort of women enrolled in the Oxford Family Planning Association Study to assess mortality in users and nonusers of oral contraceptives.
-
Compared to histopathology, visual diagnosis of PID is neither accurate nor reproducible.
-
Intraperitoneal chromic phosphate did not decrease the risk of relapse or improve survival for patients with stage III epithelial ovarian cancer after a negative second-look surgery.
-
Port-site metastasis after laparoscopic surgery during chemotherapy, or when adequate chemotherapy has been given, is usually associated with poor outcome.
-
Only 5% of white women and 0.6% of black women are potential candidates for tamoxifen chemoprevention.
-
Daily administration of a low dose oral birth control pill results in significantly fewer bleeding days.
-
This week there were 2 articles in the New England Journal of Medicine that explored the link between postmenopausal hormone use and heart disease. The first article was the final analysis of the Prempro® arm of the WHI.
